Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Ovarian Neoplasms

  Free Subscription


Articles published in Int J Gynaecol Obstet

Retrieve available abstracts of 49 articles:
HTML format



Single Articles


    July 2021
  1. KIM SR, Maganti M, Bernardini MQ, Laframboise S, et al
    Efficacy and toxicity of intraperitoneal chemotherapy as compared to intravenous chemotherapy in the treatment of patients with advanced ovarian cancer.
    Int J Gynaecol Obstet. 2021 Jul 2. doi: 10.1002/ijgo.13813.
    PubMed     Abstract available


    May 2021
  2. PITARCH-MARTINEZ M, Blanco-Elena JA, Robles-Quesada MT, Alberca-Paramo A, et al
    Colonic perforation due to ovarian cancer invasion: An unusual event.
    Int J Gynaecol Obstet. 2021 May 29. doi: 10.1002/ijgo.13770.
    PubMed     Abstract available


  3. D'ALESSANDRO G, Frigerio M, Barra F, Costantini S, et al
    Systematic review and meta-analysis on the impact of the levonorgestrel-releasing intrauterine system in reducing risk of ovarian cancer.
    Int J Gynaecol Obstet. 2021 May 9. doi: 10.1002/ijgo.13737.
    PubMed     Abstract available


    April 2021
  4. DAHIYA A, Thomas V
    Response: Endometriosis and malignancy-The intriguing relationship.
    Int J Gynaecol Obstet. 2021 Apr 13. doi: 10.1002/ijgo.13688.
    PubMed    


    December 2020
  5. LI S, Li H, Tian S, Wu J, et al
    Association between ovarian and breast masses among Chinese women in Chongqing based on ultrasonography screening: A cross-sectional study.
    Int J Gynaecol Obstet. 2020 Dec 23. doi: 10.1002/ijgo.13568.
    PubMed     Abstract available


  6. KIM SR, Kotsopoulos J, Sun P, Bernardini M, et al
    The impacts of neoadjuvant chemotherapy and of cytoreductive surgery on ten-year survival from advanced ovarian cancer.
    Int J Gynaecol Obstet. 2020 Dec 16. doi: 10.1002/ijgo.13542.
    PubMed     Abstract available


    November 2020
  7. TAKEDA T, Hayashi S, Kobayashi Y, Tsuji K, et al
    Evaluation of preoperative prediction of intestinal invasion in patients with ovarian cancer.
    Int J Gynaecol Obstet. 2020 Nov 22. doi: 10.1002/ijgo.13492.
    PubMed     Abstract available


  8. PERGIALIOTIS V, Papoutsi E, Androutsou A, Tzortzis AS, et al
    Galectins-1,-3,-7,-8 and -9 as prognostic markers for survival in epithelial ovarian cancer: A systematic review and meta-analysis.
    Int J Gynaecol Obstet. 2020 Nov 6. doi: 10.1002/ijgo.13471.
    PubMed     Abstract available


  9. ESPIAU ROMERA A, Coronado Martin PJ, Choliz Ezquerro M, Cuesta Guardiola T, et al
    Value of preoperative HE4 as predictor of advanced disease in endometrioid endometrial cancer.
    Int J Gynaecol Obstet. 2020 Nov 6. doi: 10.1002/ijgo.13473.
    PubMed     Abstract available


    October 2020
  10. TOPRAK S, Sahin EA, Sahin H, Tohma YA, et al
    Risk factors for cervical stromal involvement in endometrioid-type endometrial cancer.
    Int J Gynaecol Obstet. 2020 Oct 28. doi: 10.1002/ijgo.13449.
    PubMed     Abstract available


  11. AYHAN A, Akilli H
    Prognostic factors associated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in recurrent ovarian cancer.
    Int J Gynaecol Obstet. 2020 Oct 6. doi: 10.1002/ijgo.13410.
    PubMed     Abstract available


    July 2020
  12. BULDUKOGLU OC, Turker A, Usubutun A, Salman MC, et al
    Relationship of lymph node status with survival and recurrence among women with endometrial cancer.
    Int J Gynaecol Obstet. 2020 Jul 17. doi: 10.1002/ijgo.13309.
    PubMed     Abstract available


    June 2020
  13. RODRIGUEZ J, Fletcher A, Heredia F, Fernandez R, et al
    Alternative management for gynecological cancer care during the COVID-2019 pandemic: A Latin American survey.
    Int J Gynaecol Obstet. 2020 Jun 11. doi: 10.1002/ijgo.13272.
    PubMed     Abstract available


  14. KHADRAOUI W, Tierney C, Chung S, Mutlu L, et al
    Risk-stratifying clinicopathologic criteria for ovarian preservation in premenopausal women with early stage low-risk endometrial cancer.
    Int J Gynaecol Obstet. 2020 Jun 7. doi: 10.1002/ijgo.13254.
    PubMed     Abstract available


    May 2020
  15. YOSHIHARA M, Kajiyama H, Tamauchi S, Iyoshi S, et al
    Impact of uterus-preserving surgery on Stage I primary mucinous epithelial ovarian carcinoma: A multi-institutional study with propensity score-weighted analysis.
    Int J Gynaecol Obstet. 2020 May 29. doi: 10.1002/ijgo.13244.
    PubMed     Abstract available


  16. BOGANI G, Ditto A, Pinelli C, Lopez S, et al
    Ten-year follow-up study of long-term outcomes after conservative surgery for early-stage ovarian cancer.
    Int J Gynaecol Obstet. 2020 May 16. doi: 10.1002/ijgo.13199.
    PubMed     Abstract available


    April 2020
  17. DARIO MANDATO V, Aguzzoli L
    Management of ovarian cancer during the COVID-19 pandemic.
    Int J Gynaecol Obstet. 2020 Apr 10. doi: 10.1002/ijgo.13167.
    PubMed     Abstract available


    March 2020
  18. JIN L, Zhang Y, Yang W
    Chemotherapy-induced peripheral neuropathy among patients with ovarian cancer.
    Int J Gynaecol Obstet. 2020 Mar 4. doi: 10.1002/ijgo.13137.
    PubMed     Abstract available


    December 2019
  19. HERNANDEZ-NIETO C, Lee JA, Gonzalez K, Mukherjee T, et al
    Conservative treatment versus surgical excision of ovarian dermoid cysts: Impact on ovarian stimulation and IVF cycle success.
    Int J Gynaecol Obstet. 2019 Dec 11. doi: 10.1002/ijgo.13083.
    PubMed     Abstract available


    November 2019
  20. CHONGYUAN Z, Honglan Z, Yue W, Heng C, et al
    Para-aortic lymphadenectomy below inferior mesenteric artery versus renal vessels in stage IIIC epithelial ovarian cancer: A comparison of surgical outcomes.
    Int J Gynaecol Obstet. 2019 Nov 20. doi: 10.1002/ijgo.13061.
    PubMed     Abstract available


    October 2019
  21. VERMA S, Bakshi D, Sharma V, Sharma I, et al
    Genetic variants of DNAH11 and LRFN2 genes and their association with ovarian and breast cancer.
    Int J Gynaecol Obstet. 2019 Oct 12. doi: 10.1002/ijgo.12997.
    PubMed     Abstract available


    September 2019
  22. SALMAN L, Sabah G, Jakobson-Setton A, Raban O, et al
    Neutrophil-to-lymphocyte ratio as a prognostic factor in advanced stage ovarian carcinoma treated with neoadjuvant chemotherapy.
    Int J Gynaecol Obstet. 2019 Sep 30. doi: 10.1002/ijgo.12986.
    PubMed     Abstract available


  23. DAKHLY DMR, Gaafar HM, Sediek MM, Ibrahim MF, et al
    Diagnostic value of the International Ovarian Tumor Analysis (IOTA) simple rules versus pattern recognition to differentiate between malignant and benign ovarian masses.
    Int J Gynaecol Obstet. 2019 Sep 13. doi: 10.1002/ijgo.12970.
    PubMed     Abstract available


    August 2019
  24. CHEN L, Wang X, Shu J, Xu S, et al
    Diagnostic value of serum D-dimer, CA125, and neutrophil-to-lymphocyte ratio in differentiating ovarian cancer and endometriosis.
    Int J Gynaecol Obstet. 2019 Aug 30. doi: 10.1002/ijgo.12949.
    PubMed     Abstract available


  25. INZANI F, Angelico G, Santoro A, Musarra T, et al
    A new entity in the pathological spectrum of vulvar neoplasms: The first report of a primary endometrioid adenocarcinoma.
    Int J Gynaecol Obstet. 2019 Aug 2. doi: 10.1002/ijgo.12936.
    PubMed     Abstract available


    June 2019
  26. AUEKITRUNGRUENG R, Tinnangwattana D, Tantipalakorn C, Charoenratana C, et al
    Comparison of the diagnostic accuracy of International Ovarian Tumor Analysis simple rules and the risk of malignancy index to discriminate between benign and malignant adnexal masses.
    Int J Gynaecol Obstet. 2019 Jun 17. doi: 10.1002/ijgo.12891.
    PubMed     Abstract available


    May 2019
  27. JU UC, Kang WD, Kim SM
    The effect of concurrent endometriosis on the prognosis of women with ovarian clear cell or endometrioid carcinoma.
    Int J Gynaecol Obstet. 2019 May 13. doi: 10.1002/ijgo.12861.
    PubMed     Abstract available


    March 2019
  28. SOOKRAM J, Zheng A, Linden KM, Morgan AB, et al
    Epigenetic therapy can inhibit growth of ovarian cancer cells and reverse chemoresistant properties acquired from metastatic omentum.
    Int J Gynaecol Obstet. 2019 Mar 3. doi: 10.1002/ijgo.12800.
    PubMed     Abstract available


    January 2019
  29. DITTO A, Leone Roberti Maggiore U, Bogani G, Martinelli F, et al
    Predictive factors of recurrence in patients with early-stage epithelial ovarian cancer.
    Int J Gynaecol Obstet. 2019 Jan 30. doi: 10.1002/ijgo.12769.
    PubMed     Abstract available


    November 2018
  30. LEE DY, Kim HJ, Lee JY, Choi D, et al
    Usefulness of repeat pelvic ultrasonography before surgery for benign ovarian mass.
    Int J Gynaecol Obstet. 2018 Nov 8. doi: 10.1002/ijgo.12708.
    PubMed     Abstract available


    October 2018
  31. BEREK JS, Kehoe ST, Kumar L, Friedlander M, et al
    Cancer of the ovary, fallopian tube, and peritoneum.
    Int J Gynaecol Obstet. 2018;143 Suppl 2:59-78.
    PubMed     Abstract available


  32. BASU P, Mukhopadhyay A, Konishi I
    Targeted therapy for gynecologic cancers: Toward the era of precision medicine.
    Int J Gynaecol Obstet. 2018;143 Suppl 2:131-136.
    PubMed     Abstract available


    September 2018
  33. BOGANI G, Leone Roberti Maggiore U, Chiappa V, Ditto A, et al
    The addition of lymphadenectomy to secondary cytoreductive surgery in comparison with bulky node resection in patients with recurrent ovarian cancer.
    Int J Gynaecol Obstet. 2018 Sep 8. doi: 10.1002/ijgo.12667.
    PubMed     Abstract available


    August 2018
  34. LEE YY, Lee JW, Lu L, Xu W, et al
    Impact of interval from primary cytoreductive surgery to initiation of adjuvant chemotherapy in advanced epithelial ovarian cancer.
    Int J Gynaecol Obstet. 2018 Aug 20. doi: 10.1002/ijgo.12653.
    PubMed     Abstract available


  35. ZHU F, Xu X, Shi B, Zeng L, et al
    The positive predictive value of low-density lipoprotein for recurrence-free survival in ovarian cancer.
    Int J Gynaecol Obstet. 2018 Aug 15. doi: 10.1002/ijgo.12645.
    PubMed     Abstract available


    May 2018
  36. MICHAAN N, Gortzak-Uzan L, Grisario D, Laskov I, et al
    Ethnicity-related trends in gynecologic malignancies in Israel, 1993-2013.
    Int J Gynaecol Obstet. 2018 May 9. doi: 10.1002/ijgo.12524.
    PubMed     Abstract available


    January 2018
  37. SHENG X, Zhong Y, Lu C, Peng J, et al
    Clinical study of hereditary ovarian cancer syndrome in Shandong province, East China.
    Int J Gynaecol Obstet. 2018 Jan 23. doi: 10.1002/ijgo.12447.
    PubMed     Abstract available


    November 2017
  38. MAY T, Stewart JM, Bernardini MQ, Ferguson SE, et al
    The prognostic value of perioperative, pre-systemic therapy CA125 levels in patients with high-grade serous ovarian cancer.
    Int J Gynaecol Obstet. 2017 Nov 2. doi: 10.1002/ijgo.12376.
    PubMed     Abstract available


    October 2017
  39. MINAR L, Felsinger M, Cermakova Z, Zlamal F, et al
    Comparison of the Copenhagen Index versus ROMA for the preoperative assessment of women with ovarian tumors.
    Int J Gynaecol Obstet. 2017 Oct 31. doi: 10.1002/ijgo.12371.
    PubMed     Abstract available


    August 2017
  40. SON JH, Kong TW, Paek J, Song KH, et al
    Clinical characteristics and prognostic inflection points among long-term survivors of advanced epithelial ovarian cancer.
    Int J Gynaecol Obstet. 2017 Aug 31. doi: 10.1002/ijgo.12315.
    PubMed     Abstract available


    May 2017
  41. KAPP DS, Rosenfeld EB, Chan JE, Chan JK, et al
    Factors associated with oophorectomy in children with benign ovarian masses.
    Int J Gynaecol Obstet. 2017 May 28. doi: 10.1002/ijgo.12223.
    PubMed     Abstract available


  42. LIU R, Cheng J, Chen Y, Wang W, et al
    Potential role and prognostic importance of dishevelled-2 in epithelial ovarian cancer.
    Int J Gynaecol Obstet. 2017 May 17. doi: 10.1002/ijgo.12218.
    PubMed     Abstract available


    March 2017
  43. ZHANG T, Li F, Liu J, Zhang S, et al
    Diagnostic performance of the Gynecology Imaging Reporting and Data System for malignant adnexal masses.
    Int J Gynaecol Obstet. 2017 Mar 13. doi: 10.1002/ijgo.12153.
    PubMed     Abstract available


    February 2017
  44. HILLMAN RT, Saenz CC, McHale MT, Plaxe SC, et al
    Fertility preservation and survival among young women with early ovarian cancer living in US counties with gynecologic oncologist services.
    Int J Gynaecol Obstet. 2017 Feb 7. doi: 10.1002/ijgo.12109.
    PubMed     Abstract available


    January 2017
  45. BATTARBEE A, Strohl A, Zimmerman L, Patel A, et al
    Applicability of the modified ACOG/SGO referral criteria for adnexal mass within a limited-resource setting.
    Int J Gynaecol Obstet. 2017;136:53-57.
    PubMed     Abstract available


    June 2016
  46. KIM ML, Cho YJ, Kim MK, Jung YW, et al
    The efficacy of long-term maintenance therapy with a levonorgestrel-releasing intrauterine system for prevention of ovarian endometrioma recurrence.
    Int J Gynaecol Obstet. 2016 Jun 4. pii: S0020-7292(16)30164.
    PubMed     Abstract available


  47. LIAN C, Chen X, Ni Y, Huang X, et al
    Pregnancy after fertility-sparing surgery for borderline ovarian tumors.
    Int J Gynaecol Obstet. 2016 Jun 3. pii: S0020-7292(16)30165.
    PubMed     Abstract available


    March 2016
  48. PARK JY, Suh DS, Kim JH, Kim YM, et al
    Outcomes of fertility-sparing surgery among young women with FIGO stage I clear cell carcinoma of the ovary.
    Int J Gynaecol Obstet. 2016 Mar 11. pii: S0020-7292(16)30006.
    PubMed     Abstract available


    February 2016
  49. VAN DEN AKKER PA, Zusterzeel PL, Aalders AL, Snijders MP, et al
    Use of risk of malignancy index to indicate frozen section analysis in the surgical care of women with ovarian tumors.
    Int J Gynaecol Obstet. 2016 Feb 24. pii: S0020-7292(16)00097.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: